Medical Condition News

RSS

Unigene to present proprietary recombinant production, oral peptide drug delivery technology at TIDES Summit

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company will be presenting a poster and an oral presentation on its propriety recombinant production and oral peptide drug delivery technology during the upcoming 2011 TIDES: Oligonucleotide and Peptide Research, Technology and Product Development Summit being held at the Hynes Convention Center and Sheraton Boston Hotel in Boston, MA from May 22 - 25, 2011.

18 May 2011

Mobile phones could help improve diabetes management in under-developed countries

A new study by the Veterans Affairs Ann Arbor Healthcare System and University of Michigan suggests that mobile phones could help low-income patients across the globe manage diabetes and other chronic diseases.

18 May 2011

Intermittent hypoxia enhances cancer growth in mouse model of obstructive sleep apnea

A new study links the intermittent interruption of breathing that occurs in patients with obstructive sleep apnea to enhanced proliferation of melanoma cancer cells and increased tumor growth in mice, according to researchers in Spain.

18 May 2011

Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting

Bayer HealthCare Pharmaceuticals, Inc. announced today that data evaluating several of its investigational oncology compounds will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology, June 3-7, in Chicago, IL.

18 May 2011

CITN selects Cytheris' CYT107 for initial clinical trials at network institutions

Cytheris SA and the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington, today announced the selection of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, as one of the first immunotherapeutic agents proposed for initial clinical trials at network institutions.

18 May 2011

Epstein-Barr virus might cause multiple sclerosis, study confirms

The Epstein-Barr (EVB) virus -belonging to the herpesviruses family, which also includes the herpes simplex virus and the cytomegalovirus- is one of the environmental factors that might cause multiple sclerosis, a condition affecting the central nervous system, which causes are unknown.

18 May 2011

Study: MMN might predict risk of developing schizophrenia

There is a significant need for objective tests that could improve clinical prediction of future psychosis. One strategy has been to determine whether physiologic measures that are abnormal in people diagnosed with schizophrenia might also be useful in estimating the risk for developing this illness. This is the strategy taken by German and Swiss researchers in the current issue of Biological Psychiatry.

18 May 2011

NCNPR and Cancer Institute in Jackson partner for anti-cancer drug research

A new partnership to search for cancer-fighting drugs combines compound-identification and screening expertise at the University of Mississippi's National Center for Natural Products Research with the drug development and clinical-trials capabilities at the University of Mississippi Medical Center Cancer Institute.

18 May 2011

Novel gene associated with heart development and aging process

Researchers at the University of Ottawa Heart Institute (UOHI) have identified a novel gene in the nucleus of muscle and brain cells that affects heart development and the aging process. Their investigation brings the promise of new treatments for an old, failing heart.

18 May 2011

Gut bacteria influences brain chemistry and behaviour: Research

For the first time, researchers at McMaster University have conclusive evidence that bacteria residing in the gut influence brain chemistry and behaviour.

18 May 2011

Treatment of chronic low back pain can reverse abnormal brain activity and function

It likely comes as no surprise that low back pain is the most common form of chronic pain among adults. Lesser known is the fact that those withchronic pain also experience cognitive impairments and reduced gray matter in parts of the brain associated with pain processing and the emotional components of pain, like depression and anxiety.

18 May 2011

Tips to get better sleep

Your life is already tense — teens rebelling, house under renovation, work life in overload, bills piling up, elderly parents declining — yet the demands requiring your attention and time continue to grow, overflowing into sleep-time territory. Oftentimes, mass marketing's solutions to women's challenging lifestyles focus on quick fixes and more consumer goods.

18 May 2011

TurboCharged weight-loss book now available for readers in France

TurboCharged, a new book by brother and sister co-authors Dian Griesel, Ph.D. and Tom Griesel, outlines a revolutionary 8-step rapid fat-loss program requiring no aerobic exercise, supplements or special equipment.

18 May 2011

Impaired ability to handle oxidative stress may contribute to asthma development

An impaired ability to handle oxidative stress that arises from exposure to secondhand smoke and other environmental triggers may contribute to the development of asthma, according to results obtained from the Shanghai Women's Health Asthma and Allergy Study. The results of the study suggest regulating the body's antioxidant defense system may play an important role in asthma prevention.

18 May 2011

Endo and Bioniche present Urocidin Phase III trial preliminary results at 2011 AUA annual meeting

Endo Pharmaceuticals and Bioniche Life Sciences today presented Phase III trial results for the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin, during a podium presentation at the 2011 American Urological Association annual meeting in Washington, D.C.

18 May 2011

The Incubation Factory, UMDNJ and NJIT partner to commercialize personal tonometer for glaucoma

NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.

18 May 2011

Leucine deprivation triggers apoptosis in melanoma cells

Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention.

18 May 2011

Study offers new understanding of cell signaling networks tied to diabetes and cancer

Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders.

18 May 2011

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.

18 May 2011

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Panel of Biomarkers for Peripheral Artery Disease" to the company.

18 May 2011

Medical Condition News

Unigene to present proprietary recombinant production, oral peptide drug delivery technology at TIDES Summit

Mobile phones could help improve diabetes management in under-developed countries

Intermittent hypoxia enhances cancer growth in mouse model of obstructive sleep apnea

Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting

CITN selects Cytheris' CYT107 for initial clinical trials at network institutions

Epstein-Barr virus might cause multiple sclerosis, study confirms

Study: MMN might predict risk of developing schizophrenia

NCNPR and Cancer Institute in Jackson partner for anti-cancer drug research

Novel gene associated with heart development and aging process

Gut bacteria influences brain chemistry and behaviour: Research

Treatment of chronic low back pain can reverse abnormal brain activity and function

Tips to get better sleep

TurboCharged weight-loss book now available for readers in France

Impaired ability to handle oxidative stress may contribute to asthma development

Endo and Bioniche present Urocidin Phase III trial preliminary results at 2011 AUA annual meeting

The Incubation Factory, UMDNJ and NJIT partner to commercialize personal tonometer for glaucoma

Leucine deprivation triggers apoptosis in melanoma cells

Study offers new understanding of cell signaling networks tied to diabetes and cancer

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

USPTO issues notice of allowance to Vermillion's Peripheral Artery Disease biomarker patent

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News